We are live on ! Find out more
PA

Parallel Advisors Portfolio holdings

AUM $6.56B
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+8.88%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.4%
10 Year Est. Return
AUM
$5B
AUM Growth
+$569M
Cap. Flow
+$92M
Cap. Flow %
1.84%
Top 10 Hldgs %
38.84%
Holding
3,762
New
250
Increased
1,451
Reduced
1,277
Closed
224

Sector Composition

Rank Sector Weight
1 Technology 17.21%
2 Healthcare 9.68%
3 Financials 7.2%
4 Communication Services 5.16%
5 Consumer Discretionary 4.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AWI icon
1501
Armstrong World Industries
AWI
$7.75B
$74.6K ﹤0.01%
459
+103
+29% +$15.3K
QS icon
1502
QuantumScape Corp
QS
$3.81B
$74.5K ﹤0.01%
11,083
+5,292
+91% +$22.4K
PPC icon
1503
Pilgrim's Pride
PPC
$6.31B
$74.4K ﹤0.01%
1,655
+224
+16% +$11K
AN icon
1504
AutoNation
AN
$6.88B
$74.4K ﹤0.01%
375
+117
+45% +$21.1K
ACWV icon
1505
iShares MSCI Global Min Vol Factor ETF
ACWV
$3.38B
$74.3K ﹤0.01%
627
AMX icon
1506
America Movil
AMX
$71.7B
$74.1K ﹤0.01%
4,129
-106
-3% -$1.76K
IONS icon
1507
Ionis Pharmaceuticals
IONS
$9.46B
$74K ﹤0.01%
1,872
+1,127
+151% +$36.9K
DXJ icon
1508
WisdomTree Japan Hedged Equity Fund
DXJ
$7.43B
$73.9K ﹤0.01%
647
+13
+2% +$1.42K
VOOV icon
1509
Vanguard S&P 500 Value ETF
VOOV
$6.76B
$73.8K ﹤0.01%
391
+1
+0.3% +$180
IBKR icon
1510
Interactive Brokers
IBKR
$41.1B
$73.8K ﹤0.01%
1,332
-52
-4% -$2.47K
DAC icon
1511
Danaos Corp
DAC
$2.52B
$73.6K ﹤0.01%
853
+90
+12% +$7.38K
FENI icon
1512
Fidelity Enhanced International ETF
FENI
$11.3B
$73.4K ﹤0.01%
2,206
BHF icon
1513
Brighthouse Financial
BHF
$3.46B
$73.3K ﹤0.01%
1,364
+222
+19% +$12.5K
FDMT icon
1514
4D Molecular Therapeutics
FDMT
$582M
$73.3K ﹤0.01%
19,745
CBT icon
1515
Cabot Corp
CBT
$4.46B
$73.1K ﹤0.01%
975
-105
-10% -$8.03K
GFS icon
1516
GlobalFoundries
GFS
$27.5B
$72.9K ﹤0.01%
1,909
+807
+73% +$29.3K
COKE icon
1517
Coca-Cola Consolidated
COKE
$12.4B
$72.9K ﹤0.01%
653
-57
-8% -$6.88K
REYN icon
1518
Reynolds Consumer Products
REYN
$5.51B
$72.7K ﹤0.01%
3,395
+3,233
+1,996% +$73.2K
AMCR icon
1519
Amcor
AMCR
$21.8B
$72.7K ﹤0.01%
1,582
+359
+29% +$16.6K
VGLT icon
1520
Vanguard Long-Term Treasury ETF
VGLT
$10.3B
$72.6K ﹤0.01%
1,293
TPG icon
1521
TPG
TPG
$7.93B
$72.4K ﹤0.01%
1,380
+420
+44% +$20.1K
TMC icon
1522
TMC The Metals Company
TMC
$1.92B
$72.3K ﹤0.01%
10,958
-24,659
-69% -$94.6K
WST icon
1523
West Pharmaceutical
WST
$24.8B
$72K ﹤0.01%
329
+40
+14% +$8.55K
FNDB icon
1524
Schwab Fundamental US Broad Market Index ETF
FNDB
$1.47B
$71.9K ﹤0.01%
2,999
+1,499
+100% +$34.1K
STIP icon
1525
iShares 0-5 Year TIPS Bond ETF
STIP
$15.9B
$71.9K ﹤0.01%
699
+584
+508% +$59.9K

Similar funds

Parallel Advisors's Q2 2025 Portfolio in Review

As of Q2 2025, Parallel Advisors held 3,762 positions worth $5B, up 13% from $4.43B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Parallel Advisors's Q2 2025 filing shows 250 new, 1,451 increased, 1,277 reduced and 224 closed positions. Its largest new stake was Vanguard 0-3 Month Treasury Bill ETF: 32,722 shares worth $2.47M. The largest sale was Corcept Therapeutics, an estimated $7.34M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.

  • Parallel Advisors's largest Q2 2025 buy was Vanguard 0-3 Month Treasury Bill ETF: 32,722 shares worth $2.47M.
  • Parallel Advisors added most to iShares Core S&P 500 ETF in Q2 2025, an estimated $18.4M increase.
  • Parallel Advisors's biggest Q2 2025 reduction was Corcept Therapeutics, cutting an estimated $7.34M.
  • Parallel Advisors fully exited Discover Financial Services in Q2 2025, selling an estimated $1.22M.
  • Parallel Advisors's ten largest holdings make up 39% of its $5B portfolio in Q2 2025.
  • Parallel Advisors opened 250 new positions and closed 224 in Q2 2025.
  • Parallel Advisors's portfolio value rose 13% quarter-over-quarter to $5B.

Based on Parallel Advisors's 13F filing for Q2 2025, filed 8 Jul 2025.